LifeSignals Group recently announced that it received FDA 510(k) clearance for its LifeSignals ECG remote monitoring patch platform. This wireless biosensor allows healthcare professionals to continuously collect electrocardiography (ECG) and heart rate data from patients without needing to be in close proximity to them. The flexibility that this technology affords is becoming more and more critical as uncertainty continues to affect the course of managing the global COVID-19 pandemic. Wearable medical devices put more responsibility in the hands of the patients themselves, allowing them to be more independent while simultaneously making tracking infectious disease outbreaks more efficient.

Read More:

https://www.prnewswire.com/news-releases/wearable-amedical-devices-give-patients-the-ability-to-be-more-independent-301094542.html

https://www.massdevice.com/lifesignals-wireless-biosensor-wins-fda-clearance/

https://www.prnewswire.com/news-releases/wearable-diagnostic-devices-help-ease-pressure-on-healthcare-systems-301099953.html